FundedIQ
Biotechnology

Oruka Therapeutics: Funding, Investors & Team (Oct 2026)

Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.

www.orukatx.com LinkedIn Waltham, United States 51-100 employees
Total raised
$700M
Rounds
1
Latest
Undisclosed round
Apr 2026

Oruka Therapeutics has raised $700M across 1 funding round on record, the most recent an undisclosed round of $700M announced in Apr 2026.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Oruka Therapeutics Company Profile and Key Stats

Total funding raised
$700M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$700M in Apr 2026
Employees
51-100
reported band
Headquarters
Waltham, United States

Latest funding round on record: Apr 2026.

Oruka Therapeutics Funding Rounds

Date
Round
Amount
Undisclosed round
$700M

Oruka Therapeutics Founders and Leadership Team

Name
Role
Contact
Lawrence Klein
Founder
—

No contact details are on record for this team yet.

Oruka Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Oruka Therapeutics' latest round of $700M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Oruka Therapeutics in Biotechnology and Waltham

Companies Similar to Oruka Therapeutics

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Oruka Therapeutics Funding FAQs

What does Oruka Therapeutics do?

Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.

How much funding has Oruka Therapeutics raised?

Oruka Therapeutics has raised $700M across 1 round on record. The most recent is an undisclosed round of $700M announced in Apr 2026.

When did Oruka Therapeutics last raise funding?

Oruka Therapeutics' most recent funding round on record is an undisclosed round of $700M, announced in Apr 2026.

Who founded Oruka Therapeutics?

FundedIQ lists Lawrence Klein (Founder) at Oruka Therapeutics.

Where is Oruka Therapeutics headquartered?

Oruka Therapeutics is based in Waltham, Massachusetts, United States.

How many employees does Oruka Therapeutics have?

Oruka Therapeutics is in the 51-100 employee band.

How does Oruka Therapeutics' funding compare to other Biotechnology startups?

Oruka Therapeutics' latest round of $700M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Oruka Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oruka Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.